[1] ZAPATA E,ZUBIAURRE L,CASTIELLA A,et al.Are hepatocellular carcinoma surveillance programs effective at improving the therapeutic options[J]. Rev esp enferm dig(Madrid),2010,102(8):484-488. [2] BRUIX J,SHERMAN M.Management of hepatocellular carcinoma: an update[J]. Hepatology,2011,53(3):1020-1022. [3] 叶胜龙,陈荣新. 2010年美国肝病学会肝细胞癌临床指南更新版解读[J]. 中国医学前沿杂志(电子版),2011,3 (1):17-20. [4] RYOSUKE T,HARUHIKO Y,YUTAKA M,et al.Diagnostic accuracy of tumor markers for hepatocellular carcinoma:a systematic review[J]. Hepatol Int,2008,2(1):17-30. [5] MARRERO JA,FENG Z,WANG Y,et al.Alpha-fetoprotein, des-gamma carboxyprothrombin,and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma[J]. Gastroenterology,2009,137(1):110-118. [6] FARINATI F,MARINO D,DE GIORGIO M,et al.Diagnostic and prognostic role of α-fetoprotein in hepatocellular carcinoma:both or neither[J]. Am.J.Gastroenterol,2006,101(3):524-532. [7] ISHIKAWA K,SASAKI A,HARAGUCHI N,et al.A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin[J]. Oncologist,2007,12(3):320-324. [8] FORNER A,REIG M,BRUIX J.Alpha-fetoprotein for hepatocellular carcinoma diagnosis:the desmise of a brilliant star[J]. Gastroenterology,2009,137(1):26-29. [9] SAKATA J,SHIRAI Y,WAKAI T,et al.Preoperative predictors of vascular invasion in hepatocellular carcinoma[J]. Eur J Surg Oncol,2008,34(8):900-905. [10] KIM BK,AHN SH,SEONG JS,et al.Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma[J]. Liver Int,2011,31(3):369-376. [11] NOBUOKA D,KATO Y,GOTOHDA N,et al.Postoperative serum alpha-fetoprotein level is a useful predictor of recurrence after hepatectomy for hepatocellular carcinoma[J]. Oncol Rep,2010,24(2):521-528. [12] LEERAPUN A,SURAVARAPU S,BIDA J,et al.The utility of AFP-L3% in the diagnosis of hepatocellular carcinoma:evaluation in A U.S.referral population[J]. Clin Gastroenterol Hepatol,2007,5(3):394-267. [13] TOYODA H,KUMADA T,TADA T,et al.Clinical utility of highly sensitive Lens culinaris agglutinin-reactive alpha-fetoprotein in hepatocellular carcinoma patients with alpha-fetoprotein<20ng/mL[J]. Cancer Sci,2011 Jan 18.[Epub ahead of print]. [14] TOYODA H,KUMADA T,KANEOKA Y,et al.Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC[J]. Hepatology,2008,49(2):223-232. [15] TAMURA Y,IGARASHI M,SUDA T,et al.Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment[J]. Dig Dis Sci,2010,55(7):2095-2101. [16] DURAZO FA,BLATT LM,COREY WG,et al.Des-gamma-carboxyprothrombin,alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis,cirrhosis and hepatocellular carcinoma[J]. J Gastroenterol Hepatol,2008,23(10):1541-1548. [17] ISHIDA H,MATSUO S,INOUE Y.Evaluation of diagnostic performance of alpha-fetoprotein (AFP) and des-gamma-carboxy prothrombin (DCP) for HCV related hepatocellular carcinoma developed after long-term follow up[J]. Rinsho Byori,2010,58(11):1065-1072. [18] YAMAMOTO K,IMAMURA H,MATSUYAMA Y,et al.Significance of alpha-fetoprotein and des-c-carboxy prothrombin in patients with hepatocellular carcinoma under going hepatectomy[J]. Ann Surg Oncol,2009,16(10):2795-2804. [19] NAKAMURA S,NOUSO K,SAKAGUCHI K,et al.Sensitivity and specificity of des-gamma-carboxy prothrombin for diagnosis of patients with hepatocellular carcinomas varies according to tumor size[J]. Am J Gastroenterol,2006,101(9):2038-2043. [20] ITOH S,MORITA K,UEDA S,et al.Long-term results of hepatic resection combined with intraoperative local ablation therapy for patients with multinodular hepatocellular carcinomas[J]. Ann Surg Oncol,2009,16(12):3299-3307. [21] GAO FJ,CUI SX,CHEN MH,et al.Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells[J]. Life Sci,2008,83(23-24):815-820. [22] FUJIKAWA T,SHIRAHAL H,UEDA N,et al.Des-γ-carboxyl prothrombin-promted vascular endothelial cell proliferation and migration[J]. Biol Chem,2007,282(12):8741-8748. [23] HAGIWARA S,KUDO M,KAWASAKI T,et al.Prognostic factors for portal venous invasion in pat ients with hepatocellular carcinoma [J]. Gastroenterology,2006,41(12):1214-1219. [24] INAGAKI Y,TANG W,MAKUUCHI M,et al.Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin[J]. Liver Int,2011,31(1):22-35. [25] ZINKIN NT,GRALL F,BHASKAR K,et al.Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease[J]. Clin Cancer Res,2008,14(2):470-477. |